ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 302 out of 1121

$533K Total Retail Price of All Prescriptions

Rank: 368 out of 1121

255 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 255 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 524 401 1 4
OMEPRAZOLE 418 351 2 6
SIMVASTATIN 397 334 3 1
FUROSEMIDE 371 304 4 7
GABAPENTIN 290 240 5 13
LEVOTHYROXINE SODIUM 288 237 6 2
PRAVASTATIN SODIUM 271 252 7 14
POTASSIUM CHLORIDE 242 205 8 12
METFORMIN HCL 223 164 9 8
WARFARIN SODIUM 220 208 10 11
FAMOTIDINE 202 136 11 63
CITALOPRAM HBR 189 176 12 18
MELOXICAM 186 158 13 22
ALENDRONATE SODIUM 181 157 14 37
AMLODIPINE BESYLATE 164 147 15 5
TAMSULOSIN HCL 152 99 16 32
ATENOLOL 137 104 17 16
HYDROCHLOROTHIAZIDE 135 122 18 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 102 19 31
DIOVAN 128 128 20 45
METOPROLOL SUCCINATE 123 113 21 23
GLYBURIDE 120 94 R 22 51
EXELON 111 111 23 119
TRAMADOL HCL 111 110 23 25
CLOPIDOGREL 110 89 25 27
LOVASTATIN 109 72 26 26
ALLOPURINOL 108 82 27 30
LANTUS 103 79 28 52
NAMENDA 101 101 29 53
METOPROLOL TARTRATE 96 73 30 9
SERTRALINE HCL 95 80 31 21
COMBIVENT 94 66 32 129
PROAIR HFA 89 49 33 48
ZETIA 88 51 34 80
INSULIN SYRINGE 88 70 34 77
PLAVIX 86 72 36 42
ZOLPIDEM TARTRATE 83 82 37 19
CARBIDOPA-LEVODOPA 82 81 38 118
CIPROFLOXACIN HCL 76 66 39 57
DILTIAZEM 24HR CD 75 75 40 99
CARVEDILOL 75 41 40 20
POLYETHYLENE GLYCOL 3350 72 49 42 70
LOSARTAN POTASSIUM 67 67 43 17
CRESTOR 65 52 44 28
DONEPEZIL HCL 65 65 44 35
DIGOXIN 64 40 46 59
NEXIUM 63 63 47 24
GEMFIBROZIL 63 36 47 88
GLIMEPIRIDE 60 44 49 34
CYMBALTA 54 54 50 50
LEVEMIR 54 50 50 157
PREDNISONE 54 53 50 43
SINGULAIR 52 29 53 78
PAROXETINE HCL 52 43 53 58
FINASTERIDE 51 51 55 117
AMOX TR-POTASSIUM CLAVULANATE 51 38 55 101
SPIRONOLACTONE 50 50 57 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.